Background/aim: Although some patients with enchondroma have multiple lesions, no study has investigated the distribution of lesions in patients with multiple enchondromas.

Patients And Methods: This retrospective study included 118 patients with enchondroma of the hand. The incidence and characteristic feature of multiple enchondromas of the hand were investigated.

Results: Four patients (3.4%) had multiple enchondromas. In all the patients with multiple enchondromas, the lesions occurred in the middle phalanx, proximal phalanx, and metacarpal bone in the same digital ray.

Conclusion: The development of the hand rapidly progresses from intrauterine day 33 to day 54. The digital rays are evident on intrauterine day 41, and separation of the distal phalanx, middle phalanx, proximal phalanx, and metacarpal bone is completed until intrauterine day 54. The successive occurrence of multiple enchondroma lesions in the same digital ray in all four cases suggests that the occurrence of lesions preceded the separation of the hand bones and the lesions were divided during the development of these bones.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6899104PMC
http://dx.doi.org/10.21873/invivo.11728DOI Listing

Publication Analysis

Top Keywords

multiple enchondromas
16
intrauterine day
12
enchondromas hand
8
patients enchondroma
8
patients multiple
8
middle phalanx
8
phalanx proximal
8
proximal phalanx
8
phalanx metacarpal
8
metacarpal bone
8

Similar Publications

How do lesions affect limb lengthening in children with Ollier's disease?

BMC Musculoskelet Disord

January 2025

Department of Pediatric Orthopaedics, Children's Hospital of Fudan University, National Children's Medical Center, 399 Wanyuan Rd, Minhang District, Shanghai, 201102, China.

Purpose: Ollier's disease (multiple enchondromatosis) can cause severe lower limb length discrepancy and deformity in children. Osteotomy and limb lengthening with external fixation can correct the lower extremity deformity. There may be lesions in the osteotomy part (OP), and the internal fixation part of the external fixation(FP).

View Article and Find Full Text PDF

Spectrum of IDH-mutant tumors in Ollier-Maffucci disease: the triple interaction theory.

Orphanet J Rare Dis

November 2024

Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neuro-oncologie, Paris, France.

Article Synopsis
  • The study aims to enhance understanding of tumor development in patients with Ollier disease (OD) and Maffucci syndrome (MS), focusing on IDH-mutated tumors and their origins.
  • It proposes that a single IDH-mutant cell could lead to various tumors due to early embryonic mutations and that not all mutated cells will display the IDH mutant characteristics.
  • Additionally, it suggests that specific genetic predispositions (SNPs) may increase the likelihood of developing particular tumors in these patients, linking developmental defects to tumor occurrence.
View Article and Find Full Text PDF

Enchondromas are a common tumor in bone that can occur as multiple lesions in enchondromatosis, which is associated with deformity of the affected bone. These lesions harbor somatic mutations in IDH and driving expression of a mutant Idh1 in Col2 expressing cells in mice causes an enchondromatosis phenotype. Here we compared growth plates from E18.

View Article and Find Full Text PDF
Article Synopsis
  • * A 17-year-old boy had a long-standing swelling in his thigh, and imaging indicated possible malignant changes, yet the tumor was ultimately found to be benign upon surgical removal and histopathological examination.
  • * In cases with unclear diagnoses like this, performing an excisional biopsy is recommended to ensure proper management and monitoring for any future issues or recurrences.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!